【Company Research】Xiaomi (1810 HK) - Xiaomi EV SU7’s pricing and pre-order above expectations; Raise TP to HK$22.19 |
【Company Research】RemeGen (9995 HK) - Awaiting the fruition of overseas BD collaborations |
【Company Research】PICC P&C (2328 HK) - Non-auto CoR better than expected; sustain 40%+ payout in next two years |
【Company Research】Tigermed (300347 CH) - Expect business rebound in 2024E |
【Company Research】Joinn Laboratories (6127 HK) - Recovery could be not earlier than 1H24 |
【Company Research】Jinxin Fertility (1951 HK) - Impressive business rebound in 2023 |
【公司研究】固生堂 (2273 HK) - 业绩强势增长,源于效率提升和快速扩张 |
【Company Research】CMGE Technology (302 HK) - Eyes on strong pipeline ahead |
【Company Research】Zoomlion (000157 CH) - 2023 net profit in line; overseas strategy a successful pay-off |
【Company Research】Zoomlion (1157 HK) - 2023 net profit in line; overseas strategy a successful pay-off |